The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
A bit late if it's already in the public domain. It just makes them look like ranking amateurs, imo.
Might they (SAR) not have RNSed their participation in this, or did I miss it?
I guess the point I'm trying to make is we, the shareholders, find out about events happening courtesy of a poster on a BB/chat forum. Why is this? Another missed PR opportunity? The commercial nous - or lack thereof - is really quite breathtaking. Akin to announcing a share consolidation weeks before any EGM to discuss the matter.
Hey MrIndia, actually I'm not frustrated, I just want to highlight the psychological games that are played to persuade the uninitiated to part with their shares. It often happens just before news drops. It's actually also a good sign, as the news is likely positive. I've seen it many times before, and fell victim to it on a couple of occasions. I would simply urge investors here to read between the lines and see the MMs dropping the bid for what it is. An attempt to spook the weak hands into selling. Be careful, is all I'm saying. Just my humble opinion, each to their own, etc.
Another inconsequential UT to dull the sentiment here. Anyone would think it was a ploy to undermine confidence, or am I being cynical?
...in how to shaft shareholders. Buyers beware. I trust MW and his cronies are happy now? What goes around, comes around.
Wheeler, if the ship hasn't sailed yet, then the foghorns are blowing and the gang planks are being raised. It's been six months (and counting) since the "better than dexamethasone" claim. It seems criminal that we've seen no meaningful update since then. I didn't realize "fast tracking" was so painfully slow, but hey! Between the hare and the tortoise, who won the race? I just don't understand the apparent lack of urgency, while lives are still being lost and livelihoods are still being thrown into turmoil.
Warty, maybe the fairground that is AIM is not for you, old thing?
Sadly, the management (MW, in particular) has lost ALL TRUST. Not buying in at the current ask of 0.30p, only for those in the "inner circle" to sell at half the price, and still make money (50% minimum). They're playing the shareholders for fools. Needs to be investigated, surely?
... for repeating myself, but the OXB experience (regarding consolidation) might well be relevant here. The language used then to sell the idea of consolidation resonates here: "The Board considers the Consolidation to be in the best interests of the Company and its Shareholders. It believes that the effect of the Consolidation will be to improve market liquidity by reducing the volatility and spread of trading activity in the Company's New Consolidated Ordinary Shares and make trading in the Company's shares more attractive to a broader range of institutional investors and other members of the investing public, both overseas and in the UK." https://www.lse.co.uk/rns/OXB/proposed-share-capital-consolidation-xrvbadp9b9ihh4g.html
What's interesting is what happened next. Well, licensing deals/collaborations were announced. Lots of Directors' dealings to boot. No dilution after the consolidation, although a month prior there was a placing to raise 20m quid (yikes!). The effect on the SP (at a 50:1 consolidation)? 15p should have translated into 750p. However, the SP seems to have bottomed post-consolidation around 660p (a 12% reduction). But by a month later, the SP hit 1020p, a more than 50% increase. Thereafter, there was a decline (hastened, in no small part, by the Covid nightmare), but by September, 2021, we hit 1641p. We more than doubled in 3 years. I wouldn't be at all surprised if SAR follows the case study that is OXB - not a bad result for the LTHs amongst us? Bottom line, we all need to be patient for a while longer.
Micky, first sensible thing you've said this year (if not this decade). I appreciate other people's points of view - which is why I read these BBs. I particularly appreciate people who share their research and knowledge freely. Do I base my investment decisions on some anonymous poster's recommendation or input here? Hell no! My decision to invest here is based on my own research and therefore purely on my head, no one else's. Rampers, derampers? I couldn't care less. All I know is I'm an investor. I don't EVER short the market. I see opportunities, and I invest. For the LONG TERM. HEMO is one such investment. Enough said.
MrIndia, you keep on stating that the price is being "driven down", as if to say investors are selling in their droves. Not true, as daily volumes will confirm. If I didn't know better, I might think you were engaged in a (not-so-subtle) deramp in order to buy in cheaper yourself. Your daily belly-aching re: the direction of the SP is becoming boring. As I said before, IF you're an investor, best to turn off and return in a few weeks/months. In a way, you alighted on something when you said previously: "Also, biotech is being brutalised in the USA so not surprising small bio being battered here as well." Indeed. Therein lies the problem. The entire sector is being hammered, largely because Covid is now seen as less of a threat (erroneously, in my opinion), and because drug discovery companies are news-driven (i.e. no news = green light for the MMs to drop the bid). It was ever thus. We just need to hold, firm in the belief that the science will prevail. We are grossly undervalued - I think that much we can agree on? We just need the market to wake up, and catch up. AIMHO.
MrIndia, on December 17th the SP closed at 1.48p. On January 6th the SP stood at 2.05p. That's just shy of a 40% increase in the space of 3 weeks. There was bound to be some profit-taking from the chinless wonders that trade this stock. If you're an investor, on the other hand, these day-to-day gyrations should only be a minor irritation, surely? Moreover, the selling that is "driving the price down" (as you put it) has been pathetic in volume terms (a few million here, a few million there). It's when we see people running for the exit with volumes in the hundreds of millions that I'll become concerned. In the interim, let the science do the talking, ignore the noise, and chill out.
https://find-and-update.company-information.service.gov.uk/officers/Lrio6WXRiI-IFjuiYMirifcK0Sk/appointments
Has a few fingers in different pies.
Hi Thoth, if there is indeed "an offer waiting in the wings", might the whole consolidation proposal be linked? In other words, potential buyer/licensee tells SAR: "We're ready to do a deal, but it might be difficult to convince our shareholders of the wisdom of buying an AIM-listed penny share company. You see, the high number of shares outstanding (over 3.3 billion) and the low absolute share price might negatively affect our shareholders' perception of Sareum. A consolidation would reduce the number of shares outstanding and increase the relative price, which would then be more attractive to our shareholders, and therefore less of a hard sell". The consolidation is a means to an end, in other words.
Someone must have posted this at the time, but I missed it. It's a good overview of where Sareum is at, for any new investors contemplating taking the plunge, or for any existing investors who might be experiencing the extreme frustration that often plagues us as we await news and who might just be thinking of jumping ship.
https://www.thearmchairtrader.com/sareum-holdings-share-price-forecast-december/
Lots to look forward to in the near future.
I'm invested here, and also in SAR. I see a lot of similarities between the 2 companies, yet HEMO has a mcap of 16m and SAR has a mcap of 167m. Either HEMO is undervalued or SAR is overvalued, I guess, but I can honestly see Hemo at 10p minimum by the end of 2022. I hate making SP predictions, by the way, so DYOR obviously. But just think HEMO is so undervalued at the moment. GLA for 2022.
3rd item on the 'GFM Live RNS' option, if you press the icon?
https://www.lse.co.uk/rns/GFM/winter-olympics-games-extension-6tgu17xdoac4k0d.html
Always useful to read through historic RNSs before making any kind of investment decision, amongst other things, of course.
Colbaltblue, I think you'll find the board has already given us "a compelling reason [actually, more than one] for the planned action" at the last AGM meeting: "The Board is of the opinion that the high number of shares outstanding (over 3.3 billion) and the low absolute share price negatively affects investors' perception of the Company and considers a share consolidation to be in the best interests of the Company and its shareholders. A consolidation would reduce the number of shares outstanding and increase the relative price, which could be more attractive to a broader range of institutional investors and other members of the investing public." Not sure what more you want them to say?
Same to you, Warty, and wish your wife a speedy recovery. Here's hoping 2022 brings you, your family, and all much happiness.
Apologies again for my clumsy attempt at humor, at what must have been a very worrying time. No excuses...
Warty, profuse apologies if I overstepped the mark yesterday. Was just trying to inject a bit of humor into what I know is a frustrating period. Being stiffed by SRRA, and now also by PH, has left a sour taste, I must admit. I just think we will get our just reward in the end, so long as we hang in there. Hope that I'm still alive to enjoy the spoils mind you.